A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study.

Autor:	Erik Lipšic, Peter van der Meer, Adriaan Voors, B. Westenbrink, Ad van den Heuvel, Hetty de Boer, Anton van Zonneveld, Regien Schoemaker, Wiek van Gilst, Felix Zijlstra, Dirk van Veldhuisen
Předmět:	ERYTHROPOIETIN MYOCARDIAL infarction CORONARY disease BLOOD circulation disorders
Zdroj:	Cardiovascular Drugs & Therapy; Apr2006, Vol. 20 Issue 2, p135-141, 7p
Abstrakt:	Aims: Besides stimulating hematopoiesis, erythropoietin (EPO) protects against experimental ischemic injury in the heart. The present study evaluated the safety and tolerability of EPO treatment in non-anemic patients with acute myocardial infarction (MI). [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink